25/11/2020 Aptamer Group Ltd, the developer of diagnostic and therapeutic aptamer reagents, is pleased to announce further progress in their collaboration with Integumen plc (AIM: SKIN) to develop Microtox PD,…

09/07/2020 Collaboration to use aptamers in a device to detect SARS-CoV-2 in wastewater Aptamer Group, developers of Aptamer reagents, is pleased to announce that it has signed…

08/01/2019 Aptamer Group today announced it has signed an agreement with AstraZeneca to explore the potential of using aptamer technology to target the kidney. The two-year agreement will give AstraZeneca…